Dr. Amy Abernethy Profile picture
Principal Deputy Commissioner and Acting CIO at @US_FDA
May 23, 2019 9 tweets 2 min read
Today I wanted to pick back up on the cannabidiol (CBD) theme. It remains top of mind. You may have noticed that many products containing CBD are being introduced widely and are sold in many different forms, such as oil drops, capsules, lotions and tea. Other than one prescription drug product to treat rare, severe forms of epilepsy, the FDA has not approved any other CBD-containing products. We want consumers to be aware that there is only limited available information about CBD, including about its effects on the body.